TrialClinical rheumatology2017

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.

L M Ørnbjerg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.